Research Feeds

View All
Characterizing the gut microbiota in females with infertility and preliminary results of a water-soluble dietary fiber intervention study A prebiotic dietary pilot intervention restores faecal metabolites and may be neuroprotective in Parkinson’s Disease Diagnosis of the menopause: NICE guidance and quality standards Causes of Death in End-Stage Kidney Disease: Comparison Between the United States Renal Data System and a Large Integrated Health Care System Factors affecting the absorption and excretion of lead in the rat Factors associated with age at menarche, menstrual knowledge, and hygiene practices among schoolgirls in Sharjah, UAE Cadmium transport in blood serum The non-pathogenic Escherichia coli strain Nissle 1917 – features of a versatile probiotic Structured Exercise Benefits in Euthyroid Graves’ Disease: Improved Capacity, Fatigue, and Relapse Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinson’s Disease A Pilot Microbiota Study in Parkinson’s Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models Dysbiosis of the Saliva Microbiome in Patients With Polycystic Ovary Syndrome Integrated Microbiome and Host Transcriptome Profiles Link Parkinson’s Disease to Blautia Genus: Evidence From Feces, Blood, and Brain Gut microbiota modulation: a narrative review on a novel strategy for prevention and alleviation of ovarian aging Long-term postmenopausal hormone therapy and endometrial cancer

Association between heavy metals exposure and infertility among American women aged 20-44 years: A cross-sectional analysis from 2013 to 2018 NHANES data Original paper

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

June 30, 2025

  • Women’s Health
    Women’s Health

    Women’s health, a vital aspect of medical science, encompasses various conditions unique to women’s physiological makeup. Historically, women were often excluded from clinical research, leading to a gap in understanding the intricacies of women’s health needs. However, recent advancements have highlighted the significant role that the microbiome plays in these conditions, offering new insights and potential therapies. MicrobiomeSignatures.com is at the forefront of exploring the microbiome signature of each of these conditions to unravel the etiology of these diseases and develop targeted microbiome therapies.

  • Female Infertility
    Female Infertility

    Female infertility is a multifactorial condition affecting 10-15% of women of reproductive age, often caused by underlying conditions like Bacterial Vaginosis (BV), PCOS, Endometriosis, and Pelvic Inflammatory Disease (PID). Microbiome-targeted interventions (MBTIs) offer a promising approach to restoring balance, improving fertility outcomes, and addressing root causes.

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

Last Updated: 2025-06-30

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Divine Aleru

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

What was studied?

This original research article investigated the association between exposure to heavy metals, specifically cadmium (Cd), lead (Pb), mercury (Hg), and arsenic (As), and female infertility in a representative sample of American women. Using data from three cycles of the National Health and Nutrition Examination Survey (NHANES, 2013–2018), the study measured blood and urinary levels of these metals and examined their correlation with self-reported infertility. The primary aim was to clarify whether elevated levels of these toxic metals are linked to increased risk of infertility, adjusting for relevant demographic and health covariates.

Who was studied?

The study population consisted of 838 American women aged 20–44 years, selected from NHANES 2013–2018 cycles based on availability of laboratory and questionnaire data. Women with a history of hysterectomy, bilateral oophorectomy, or incomplete data were excluded. Infertility was defined via self-report, using the question: “Have you ever attempted to become pregnant for at least a year, without becoming pregnant?” The cohort was diverse in terms of ethnicity, education, and marital status, with significant differences in age and BMI between infertile and control women.

Most important findings

The study found that urinary arsenic (As) and cadmium (Cd) levels were significantly higher in infertile women compared to controls. After controlling for several covariates, including age, ethnicity, education, marital status, poverty index ratio, BMI, regular menstrual periods, pelvic infection, and smoking history, urinary arsenic remained significantly associated with infertility. Women with higher urinary As levels had a substantially increased risk of infertility. Urinary Cd was also associated with infertility in less-adjusted models, but this association weakened with full adjustment. Blood and urinary Pb levels were not associated with infertility overall, but stratified analyses revealed that both blood and urinary Pb were positively correlated with infertility in women aged 35–44 and in those with BMI ≥25, highlighting age and obesity as effect modifiers. Blood Hg was not significantly associated with infertility in any model.

Key implications

This study highlights the potential reproductive health risks posed by environmental exposure to heavy metals among women of reproductive age. The robust association between urinary arsenic and infertility suggests that arsenic exposure (likely from contaminated water or certain foods) may disrupt female reproductive function, potentially through oxidative stress and endocrine disruption. The findings also indicate that older and overweight/obese women may be more susceptible to the adverse reproductive effects of lead. From a clinical and public health perspective, these results support the need for routine monitoring of heavy metals in at-risk populations and for interventions aimed at reducing environmental exposures, especially in vulnerable subgroups. The study also highlights the value of using urine measurements to assess chronic exposure, as opposed to blood levels that may reflect only recent exposure.

Female Infertility

Female infertility is a multifactorial condition affecting 10-15% of women of reproductive age, often caused by underlying conditions like Bacterial Vaginosis (BV), PCOS, Endometriosis, and Pelvic Inflammatory Disease (PID). Microbiome-targeted interventions (MBTIs) offer a promising approach to restoring balance, improving fertility outcomes, and addressing root causes.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.